Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 51
Filtrar
1.
Kyobu Geka ; 63(3): 199-203, 2010 Mar.
Artigo em Japonês | MEDLINE | ID: mdl-20214347

RESUMO

PURPOSES: Experiences of percutaneous transthoracic needle biopsies under a guide of a real time 3 image display computed tomography (3 image CT) is reported. MATERIALS AND METHODS: Twenty seven biopsies from 23 patients were performed. For 3 image CT, Somatom was used. This equipment can render 3 pictures of serial slices on a screen simultaneously and have X-ray exploration-reduction system for both the patients (35% reduction) and operator's hands (72% reduction). RESULTS: The median size of the masses was 1.7 (0.5-6.3) cm; the median distance from the pleura to the mass was 0.66 (0-6.5) cm; and the median time to perform biopsies was 12 minutes. We had only 3 failed cases to obtain biopsied specimen (11%). COMPLICATIONS: Needle biopsy of the lung lesion under a guide of a 3 sectional CT is a safe and timesaving method with a high success rate to obtain biopsied tissues even for small lesions or difficult lesion.


Assuntos
Biópsia por Agulha/métodos , Pulmão/patologia , Tomografia Computadorizada por Raios X/métodos , Idoso , Feminino , Humanos , Imageamento Tridimensional , Pulmão/diagnóstico por imagem , Neoplasias Pulmonares/patologia , Tomografia Computadorizada por Raios X/instrumentação
2.
Langenbecks Arch Surg ; 394(4): 749-53, 2009 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-19002484

RESUMO

PURPOSE: We herein report a case with synchronous multiple liver metastases from gastric carcinoma surviving disease-free for more than 10 years after hepatic resection. METHODS: A 64-year-old male admitted to our hospital because of constitutional wariness. Preoperative diagnosis was type 1 gastric cancer at the lower third of the stomach and multiple metastases of both hepatic lobes. After we performed distal gastrectomy with regional lymphadenectomy and wedge hepatic resection for eight metastatic liver tumors, he received 5-fluoropyrimidine and platinum-based adjuvant chemotherapy during the early postoperative period. RESULTS: The pathologic examination revealed moderately differentiated gastric adenocarcinoma with regional lymph node metastasis and multiple liver metastases. The postoperative course was uneventful and the patient is doing well without disease recurrence after more than 10 years following surgery. CONCLUSION: To the best of our knowledge, this patient is the longest disease-free survivor after liver resection for synchronous multiple liver metastases from advanced gastric cancer. In this modern era of developing liver surgery and adjuvant chemotherapy, combination therapy of aggressive surgery and early postoperative adjuvant chemotherapy for advanced gastric cancer with liver metastasis may allow long-term survival in selected patients.


Assuntos
Adenocarcinoma/secundário , Neoplasias Hepáticas/secundário , Neoplasias Gástricas/patologia , Adenocarcinoma/tratamento farmacológico , Adenocarcinoma/cirurgia , Intervalo Livre de Doença , Gastrectomia , Hepatectomia , Humanos , Neoplasias Hepáticas/tratamento farmacológico , Neoplasias Hepáticas/cirurgia , Excisão de Linfonodo , Metástase Linfática , Masculino , Pessoa de Meia-Idade , Análise Multivariada , Prognóstico , Pirimidinas/uso terapêutico , Neoplasias Gástricas/cirurgia , Fatores de Tempo
3.
Cancer Epidemiol Biomarkers Prev ; 16(12): 2631-6, 2007 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-18086767

RESUMO

The detection of gastric premalignant lesions, atrophic gastritis, corpus atrophic gastritis, and intestinal metaplasia, using several potential markers was examined in Costa Rica. Depending on the lesion investigated, from a total of 223 dyspeptic patients, 58 (26.0%), 31 (13.9%), or 23 (10.3%) were histologically diagnosed with atrophic gastritis, corpus atrophic gastritis, or intestinal metaplasia, respectively. Sera were used for the measurement of pepsinogen (PG) and Helicobacter pylori CagA antibody (CagA-ab) levels by ELISA, and human genomic DNAs were used for the genotyping of interleukin (IL)-1beta (-511 and +3954), IL-10 (-1082 and -592), and IL-1RN intron 2 by PCR and RFLP. Multivariate analysis was done adjusting for sex, age, and H. pylori seropositivity. Low PG levels (L-PG; PG I < or = 70 microg/L + PG I/II < or = 3), very low PG levels (VL-PG; PG I < or = 30 microg/L + PG I/II < or = 2), and CagA-ab were individually associated with all premalignant lesions whereas IL-1beta +3954T-carrier and IL-1RN homozygous 2 allele were associated with intestinal metaplasia. VL-PG, for corpus atrophic gastritis detection, was the single marker with the highest combination of test characteristics, sensitivity (77.4%), specificity (80.7%), positive predictive value (39.3%), negative predictive value (95.7%), and seropositivity rate (27.4%), expected to improve after periodic measurements. Combined examinations of VL-PG and CagA-ab improved the specificity (92.7%) and positive predictive value (62.2%), with similar sensitivity (74.2%) and negative predictive value (95.7%). In conclusion, corpus atrophic gastritis detection with periodic measurements of serum PG, alone or in combination with CagA-ab status, to identify high gastric cancer risk, seems to be the method best suited for mass screening in Costa Rica.


Assuntos
Citocinas/genética , Infecções por Helicobacter/complicações , Programas de Rastreamento/métodos , Pepsinogênio A/sangue , Lesões Pré-Cancerosas , Neoplasias Gástricas/prevenção & controle , Anticorpos Antibacterianos/sangue , Antígenos de Bactérias/imunologia , Proteínas de Bactérias/imunologia , Ensaio de Imunoadsorção Enzimática , Feminino , Helicobacter pylori , Humanos , Masculino , Pessoa de Meia-Idade , Polimorfismo Genético , Lesões Pré-Cancerosas/sangue , Lesões Pré-Cancerosas/genética , Lesões Pré-Cancerosas/microbiologia , Valor Preditivo dos Testes
4.
Hepatogastroenterology ; 54(78): 1648-51, 2007 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-18019685

RESUMO

Xanthogranuloma is a rare type of inflammation and very few cases have been reported in the pancreas. We report two cases with xanthogranulomatous pancreatic abscess that followed acute pancreatitis. In both cases, multiple pseudocysts in the pancreatic tail were infected with several species of bacteria and Candida albicans. In one case, abdominal angiography revealed a hypoperfused pancreatic tail due to prior atherosclerotic obliteration of the celiac and superior mesenteric arteries. In the other case, the splenic artery was completely occluded by a transarterial embolization performed to treat an aneurysm that appeared in the course of pancreatitis. In both cases, distal pancreatectomy was performed as inflammation of the pancreatic tail was resistant to conventional antibiotic therapy, and pathologic examination revealed xanthogranulomatous inflammation around the pancreatic tail and spleen. Although the underlying pathogenesis is unclear, the prolonged infection and/or relative hypoxia induced by hypoperfusion are likely causative factors for the xanthogranulomatous changes in these pancreatic abscesses.


Assuntos
Histiocitose de Células não Langerhans/diagnóstico , Histiocitose de Células não Langerhans/etiologia , Pancreatite/diagnóstico , Pancreatite/etiologia , Abscesso Abdominal/etiologia , Doença Aguda , Idoso , Aneurisma/cirurgia , Angiografia , Candida albicans/metabolismo , Humanos , Imageamento Tridimensional , Inflamação , Masculino , Pessoa de Meia-Idade , Pancreatectomia/métodos , Artéria Esplênica/patologia , Tomografia Computadorizada por Raios X/métodos , Resultado do Tratamento
5.
Hepatogastroenterology ; 54(78): 1810-2, 2007 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-18019723

RESUMO

A 69-year-old female patient with an indocyanine green (ICG) excretory defect underwent hepatectomy for hepatocellular carcinoma (HCC). Abdominal computed tomography confirmed a mass lesion with central necrosis in the right anterior segment of the liver. Angiography revealed tumor stain pooling and a portal venous or arterial venous shunt. The patient was carefully evaluated and then treated by surgical resection for HCC. The pathologic examination revealed moderately differentiated HCC. Her postoperative course was uneventful. ICG excretory defect did not seem to have effect on the short-term prognosis of hepatectomy.


Assuntos
Carcinoma Hepatocelular/patologia , Carcinoma Hepatocelular/cirurgia , Corantes/farmacologia , Hepatectomia/métodos , Verde de Indocianina/farmacologia , Neoplasias Hepáticas/patologia , Neoplasias Hepáticas/cirurgia , Idoso , Angiografia/métodos , Feminino , Humanos , Regeneração Hepática , Necrose/patologia , Período Pós-Operatório , Tomografia Computadorizada por Raios X/métodos
6.
Helicobacter ; 12(5): 547-52, 2007 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-17760724

RESUMO

BACKGROUND: Associations between Helicobacter pylori gene diversity and gastric cancer have not been reported on in Costa Rica, despite its being one of the countries with the highest gastric cancer incidence and mortality rates in the world. The aim of this study was to determine the prevalence of H. pylori cagA and vacA genes and investigate whether it could be correlated with atrophic gastritis (AG) and gastric cancer (GC) in Costa Rica. MATERIALS AND METHODS: Genomic DNAs from isolates of 104 patients classified into two groups: non-atrophic gastritis group (n = 68) and atrophic gastritis group (n = 36), were subjected to PCR-based genotyping of cagA and vacA genes and their correlation with clinical outcome was investigated. Total DNA extractions from gastric tissues of 25 H. pylori-infected gastric cancer patients were utilized for comparative purposes. RESULTS: The presence of cagA (75.3%), vacA s1b (75.3%), and vacA m1 (74.2%) was detected, and colonization by strains with different vacA genotypes in the same stomach was found in 9.7% of the patients. Age- and sex-adjusted vacA s1b and vacA m1 were associated with GC while only vacA m1 was significantly associated with AG. A tendency for association between cagA and vacA s1b, and AG was reported. CONCLUSIONS: The prevalence status of the cagA and vacA (s1/m1) genes in Costa Rica seems to fall between that found in European/North American and East Asian countries, and both cagA and vacA seem to have clinical relevance in this country.


Assuntos
Antígenos de Bactérias/genética , Proteínas de Bactérias/genética , Gastrite Atrófica/fisiopatologia , Variação Genética , Infecções por Helicobacter/complicações , Helicobacter pylori/patogenicidade , Neoplasias Gástricas/fisiopatologia , Costa Rica/epidemiologia , Feminino , Gastrite Atrófica/epidemiologia , Gastrite Atrófica/microbiologia , Infecções por Helicobacter/microbiologia , Helicobacter pylori/genética , Humanos , Masculino , Pessoa de Meia-Idade , Reação em Cadeia da Polimerase , Prevalência , Neoplasias Gástricas/epidemiologia , Neoplasias Gástricas/microbiologia
7.
Hepatogastroenterology ; 54(73): 116-8, 2007.
Artigo em Inglês | MEDLINE | ID: mdl-17419243

RESUMO

Reflux esophagitis is a serious postoperative complication for patients undergoing gastrectomy. We designed a new jejunal pouch-esophagostomy to prevent reflux after proximal gastrectomy. After proximal gastrectomy, ajejunal segment about 17 cm long was folded. Side-to-side jejuno-jejunostomy was made using a linear stapler with 100-mm staples along the length at the anti-mesenteric side. A 10-cm-longjejunal pouch with a 7-cm-long apical bridge was made. Esophago-jejuno end-to-side anastomosis (pouch-esophagostomy) was made with circular stapler at the right anterior wall the apical bridge. We add "partial posterior fundoplication" like wrapping using the apical bridge of the jejunal pouch. Patients with this new anti-reflux anastomosis showed no reflux on barium meal study even in the right anterior oblique deep Trendelenburg's position. Jejunal pouch reconstruction with partial posterior wrapping provides a satisfactory result with regard to preventing reflux esophagitis.


Assuntos
Esofagite Péptica/prevenção & controle , Gastrectomia , Neoplasias Gástricas/cirurgia , Esofagite Péptica/etiologia , Gastrectomia/efeitos adversos , Humanos , Grampeamento Cirúrgico
8.
Surgery ; 141(4): 490-500, 2007 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-17383526

RESUMO

BACKGROUND: Persistence of postoperative immune dysfunction is a critical problem because it increases the risk of serious infectious complications. The mechanisms of the immune dysfunction that occur initially after non-thermal operative injury remain to be fully elucidated. METHODS: Two mouse models of operative trauma (simple laparotomy to represent minor operative injury and ileocecal resection to represent major operative injury) were used to define the characteristics of initial cytokine synthesis. Geldanamycin and thalidomide were independently added intraperitoneally before and after operative injury to examine the effect on postoperative immune dysfunction. Mice were sacrificed at scheduled times (3, 6, 12, and 24 h after operative injury) and TNF-alpha, IL-2, IL-4, and IL-10 were analyzed. Spleen was used for intracellular cytokines and RT-PCR. Sera were used for ELISA. RESULTS: Major operative injury caused an initial upregulation of IL-10 synthesis with delayed synthesis of TNF-alpha and IL-2. Minor operative injury caused an early induction of IL-2 synthesis preceded by an initial induction of IL-4 synthesis. GA caused a specific early upregulation of TNF-alpha mRNA expression and intracellular TNF-alpha synthesis. The GA and THD groups showed early serum IL-2 production with reduction of IL-10 mRNA expression and intracellular IL-10 synthesis in the early post-operative phase. CONCLUSIONS: Major and minor operative injury showed different Th1/Th2 cytokine patterns in the initial post-operative period. Geldanamycin and thalidomide improved the Th1/Th2 imbalance independently after major operative injury.


Assuntos
Benzoquinonas/uso terapêutico , Inibidores de Cisteína Proteinase/uso terapêutico , Citocinas/efeitos dos fármacos , Imunossupressores/uso terapêutico , Lactamas Macrocíclicas/uso terapêutico , Choque Cirúrgico/tratamento farmacológico , Talidomida/uso terapêutico , Animais , Benzoquinonas/farmacologia , Inibidores de Cisteína Proteinase/farmacologia , Citocinas/metabolismo , Imunossupressores/farmacologia , Interleucina-10/biossíntese , Interleucina-2/biossíntese , Interleucina-4/biossíntese , Lactamas Macrocíclicas/farmacologia , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Choque Cirúrgico/metabolismo , Células Th1/metabolismo , Células Th2/metabolismo , Talidomida/farmacologia , Fator de Necrose Tumoral alfa/biossíntese
9.
Nihon Shokakibyo Gakkai Zasshi ; 104(1): 30-5, 2007 Jan.
Artigo em Japonês | MEDLINE | ID: mdl-17230003

RESUMO

A 76-year-old man was admitted for treatment of gastric cancer that causing anorexia. Endoscopy showed the stenosis in the antrum of the stomach and multiple small nodules with erosion from the upper body to the corpus of the stomach. Total gastrectomy with Roux-en-Y reconstruction was performed. On the resected specimen, there were at least 28 nodules with erosion in the submucosal layer of the entire stomach. The lesions had no continuity with one another and were the same histological type, poorly differentiated adenocarcinoma. We diagnosed these lesions as intramural metastases of gastric cancer.


Assuntos
Adenocarcinoma/secundário , Neoplasias Gástricas/patologia , Adenocarcinoma/cirurgia , Idoso , Evolução Fatal , Gastrectomia/métodos , Mucosa Gástrica/patologia , Humanos , Metástase Linfática , Masculino , Neoplasias Gástricas/cirurgia
10.
Surg Technol Int ; 15: 37-9, 2006.
Artigo em Inglês | MEDLINE | ID: mdl-17029159

RESUMO

Intra-abdominal abscesses are one of the major complications that occur after Gastrointestinal Surgery. Therapeutic modalities include drainage and irrigation. This study describes the development of a new drainage and continuous irrigation system that results in less skin irritation and reduced dressing changes. This system involved the use of the Surgidrain open top (ALCARE, Tokyo, Japan), which consists of a sealing sheet with a drainage lumen and plastic cap. A double-lumen tube was inserted into the abscess cavity through a slit in the plastic cap. The abscess cavity could, therefore, be irrigated continuously through one lumen of the double-lumen tube, and most of the fluid could be drained through the second lumen of the double-lumen tube. Overflow fluid was drained through the Surgidrain open top drainage lumen. This system enabled better protection against skin complications and the ability to easily flush the abscess intermittently.


Assuntos
Abscesso Abdominal/etiologia , Abscesso Abdominal/terapia , Drenagem/instrumentação , Infecção da Ferida Cirúrgica/complicações , Infecção da Ferida Cirúrgica/terapia , Irrigação Terapêutica/instrumentação , Drenagem/métodos , Desenho de Equipamento , Análise de Falha de Equipamento , Humanos , Irrigação Terapêutica/métodos , Resultado do Tratamento
11.
World J Gastroenterol ; 12(33): 5357-9, 2006 Sep 07.
Artigo em Inglês | MEDLINE | ID: mdl-16981267

RESUMO

AIM: To investigate features of the posterior gastric artery (PGA) with respect to incidence, location and size by using autopsy subjects. METHODS: Autopsies were performed on 72 cadavers of adults with no history of abdominal operations. The localization of the PGA, the distance between the root of the splenic artery and the origin of the PGA, and the external diameter of the PGA were examined. RESULTS: The PGA was recognized in all patients. In 70 (97.2%) cadavers, the PGA branched from the splenic artery, and one female in this group had two PGAs. In 1 (1.4%) patient, the PGA originated from the root of the celiac trunk and in another (1.4%) patient, the PGA branched from the superior polar artery. Overall, the PGA extended for a length of 5.8-12.2 (mean, 8.4) cm from the root of the splenic artery, and the external diameter of the PGA was 1.2-3.2 (mean, 2) mm. CONCLUSION: The anatomical features of the PGA can be readily observed and characterized by autopsy. This study has provided valuable information on the features of the PGA useful in the planning of surgical treatment.


Assuntos
Artérias/anatomia & histologia , Artéria Celíaca/anatomia & histologia , Artéria Esplênica/anatomia & histologia , Estômago/irrigação sanguínea , Estômago/patologia , Idoso , Artérias/patologia , Autopsia , Cadáver , Artéria Celíaca/patologia , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Artéria Esplênica/patologia
12.
J Gastroenterol ; 41(7): 632-7, 2006 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-16932999

RESUMO

BACKGROUND: We evaluated several risk factors for gastric cancer in Costa Rican regions having contrasting gastric cancer incidence rates, despite the small dimensions of the country. METHODS: A total of 180 dyspeptic patients were classified into two groups according to the gastric cancer incidence (GCI) rate in their Costa Rican region: group A, with a high GCI rate (n = 91) and group B, with a low GCI rate (n = 89). Helicobacter pylori infection was detected by rapid urease test, Gram staining, and histological observation. Antral and corpus specimens were obtained to assess the grade of inflammation, topography of gastritis, gastric atrophy, and intestinal metaplasia by histological examination. Serum CagA antibody was measured by an antigen-specific enzyme-linked immunosorbent assay. RESULTS: There was no significant difference in H. pylori prevalence between groups A (73%) and B (63%); however, serum CagA antibody was more frequently detected in group A (79%) than in group B (54%) [P = 0.02; odds ratio (OR), 2.68]. Among patients under 60 years of age, serum CagA antibody was even more frequently detected in group A (81%) than in group B (49%) (P < 0.01; OR, 4.50). The prevalence of corpus-predominant gastritis, atrophic gastritis, and moderate/severe grades of neutrophilic infiltration was higher in serum CagA antibody-positive patients than in CagA antibody-negative patients (P = 0.003, 0.04, and 0.002, respectively). CONCLUSIONS: Infection with H. pylori possessing the cagA gene is associated with the development of severe gastric damage such as gastric atrophy, leading to gastric cancer, and probably influences the differences in GCI between Costa Rican regions.


Assuntos
Antígenos de Bactérias/metabolismo , Proteínas de Bactérias/metabolismo , Gastrite/epidemiologia , Infecções por Helicobacter/complicações , Helicobacter pylori/patogenicidade , Neoplasias Gástricas/epidemiologia , Adulto , Idoso , Anticorpos Antibacterianos/sangue , Antígenos de Bactérias/genética , Antígenos de Bactérias/imunologia , Proteínas de Bactérias/genética , Proteínas de Bactérias/imunologia , Costa Rica/epidemiologia , Feminino , Gastrite Atrófica/epidemiologia , Gastrite Atrófica/etiologia , Infecções por Helicobacter/epidemiologia , Infecções por Helicobacter/microbiologia , Helicobacter pylori/genética , Helicobacter pylori/metabolismo , Humanos , Incidência , Masculino , Metaplasia , Pessoa de Meia-Idade , Neoplasias Gástricas/etiologia
13.
Surg Today ; 36(8): 727-32, 2006.
Artigo em Inglês | MEDLINE | ID: mdl-16865518

RESUMO

A 49-year-old man underwent partial resection of the jejunum for an abdominal tumor, which was histologically confirmed to be a gastrointestinal stromal tumor (GIST). Immunohistochemistry revealed that the tumor cells were positive for c-kit, p52, and MIB-1. He underwent resection of a total of 83 recurrent tumors over the next 36 months. A computed tomography (CT) scan done a few months later showed multiple tumor recurrences. The patient was started on imatinib mesylate 400 mg/day, and 3 months later, a CT image showed an increase in tumor size but a decrease in tumor density. Subsequent CT scans showed a marked decrease in tumor size 3 months later and no evidence of tumor recurrence 9 and 12 months after the commencement of imatinib treatment. The patient remains in complete remission 31 months after the start of treatment.


Assuntos
Antineoplásicos/uso terapêutico , Tumores do Estroma Gastrointestinal/tratamento farmacológico , Piperazinas/uso terapêutico , Inibidores de Proteínas Quinases/uso terapêutico , Proteínas Tirosina Quinases/antagonistas & inibidores , Pirimidinas/uso terapêutico , Benzamidas , Tumores do Estroma Gastrointestinal/diagnóstico por imagem , Tumores do Estroma Gastrointestinal/cirurgia , Humanos , Mesilato de Imatinib , Masculino , Pessoa de Meia-Idade , Tomografia Computadorizada por Raios X
15.
Med Mol Morphol ; 39(2): 106-12, 2006 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-16821148

RESUMO

The effect of single high-dose irradiation on collagen networks in tumor cells was examined by scanning electron microscopy. MM46 tumor cells were transplanted into C3H/He mice and locally irradiated with a 30 Gy dose (6 MeV) 7-8 days posttransplantation. Mice were killed at various time points postirradiation, and tumor tissues were excised and fixed. After 2 N NaOH maceration, tissues were washed and stained with 1% tannic acid. They were then postfixed with 1% OsO4, dehydrated, and dried. The tissues were coated with gold, and the three-dimensional structure of the collagen fibers was observed using scanning electron microscopy. In the control group, the chambers formed by collagen fibers were larger on days 7 and 14 than those on days 1 and 3. In the irradiated group, the chambers were largest and most irregular in shape on day 7. The chamber size had decreased approximately 50% by day 14, and there was evidence of tumor cell regeneration. In addition, several fenestrations in the chamber wall developed in the irradiated group. Fenestrations in the collagen chamber walls surrounding tumor cells might allow transfer of metabolites that provide nutrition to the tumor cells, leading to their regeneration.


Assuntos
Colágeno/efeitos da radiação , Colágeno/ultraestrutura , Neoplasias/patologia , Neoplasias/ultraestrutura , Animais , Relação Dose-Resposta à Radiação , Feminino , Camundongos , Microscopia Eletrônica de Varredura
16.
J Gastrointest Surg ; 10(6): 911-5, 2006 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-16769551

RESUMO

We describe here a new technique for performing the large anastomosis between the jejunal pouch and the remnant stomach in patients undergoing proximal gastrectomy with jejunal pouch interposition. The biangulation method described in this report is a simpler technique than the existing triangulation anastomosis technique, requiring only two applications of a linear stapler. One row of staples forms the posterior wall of the anastomosis and the other forms the anterior wall. When used for jejunal pouch reconstruction after proximal gastrectomy in 12 cases of early gastric cancer, no evidence of anastomotic leakage or stenosis was apparent from barium meal studies or endoscopic examination. We find this biangulation technique to be a simple and safe procedure that is ideal for anastomoses of large diameter.


Assuntos
Gastrectomia/métodos , Neoplasias Gástricas/cirurgia , Grampeamento Cirúrgico/métodos , Anastomose Cirúrgica , Humanos , Suturas
17.
Int J Mol Med ; 17(5): 893-7, 2006 May.
Artigo em Inglês | MEDLINE | ID: mdl-16596277

RESUMO

STI571 is a specific inhibitor of tyrosine kinases, such as BCR-ABL, platelet-derived growth factor receptor, and c-KIT, and has recently been approved for the treatment of chronic myeloid leukemia and gastrointestinal stromal tumors (GISTs). This study demonstrated that STI571 induces cell death in the gastrointestinal stromal tumor cell line, GIST-T1. In these cells, STI571 induced pro-caspase-12 or pro-caspase-7 cleavage and it affected caspase-3 activity and induced the endoplasmic reticulum (ER)-resident chaperone, glucose-regulated protein 78. The STI571-induced cell death was blocked by the protein synthesis inhibitor, cycloheximide. Together, these results suggest that STI571 induces cell death in GIST-T1 cells, at least in part, via the ER stress response.


Assuntos
Retículo Endoplasmático/efeitos dos fármacos , Piperazinas/farmacologia , Pirimidinas/farmacologia , Antineoplásicos/farmacologia , Benzamidas , Western Blotting , Brefeldina A/farmacologia , Caspase 3 , Caspase 7 , Caspases/metabolismo , Linhagem Celular Tumoral , Sobrevivência Celular/efeitos dos fármacos , Cicloeximida/farmacologia , Retículo Endoplasmático/metabolismo , Chaperona BiP do Retículo Endoplasmático , Citometria de Fluxo , Tumores do Estroma Gastrointestinal/metabolismo , Tumores do Estroma Gastrointestinal/patologia , Proteínas de Choque Térmico/metabolismo , Humanos , Mesilato de Imatinib , Chaperonas Moleculares/metabolismo , Inibidores da Síntese de Proteínas/farmacologia , Tunicamicina/farmacologia
18.
Hepatogastroenterology ; 53(68): 313-6, 2006.
Artigo em Inglês | MEDLINE | ID: mdl-16608047

RESUMO

BACKGROUND/AIMS: Gastric carcinoma (GC) is one of the most common malignant tumors of the digestive tract and the incidence of adenocarcinoma of the upper one-third of the stomach has increased recently worldwide. The objective of this study was to analyze the clinicopathological variables in patients with GC and examine preoperative diagnosis and the medical treatment strategy of Type 1 GC. METHODOLOGY: Nine hundred and eighty-one patients with GC who underwent surgical resection between 1981 and 2002 at Kochi Medical School were studied. Thirty-five patients with Type 1 GC were compared with non-Type 1 GC patients on postoperative surgicopathological parameters, and changing trends were evaluated. RESULTS: The characteristics of patients with Type 1 GC were different from those of patients with non-Type 1 GC: Their tumors were more often in the upper one-third of the stomach (37% vs. 15%), lesions were histologically differentiated in 80% (vs. 56%), and there were more superficial lesions surrounding Type 1 GC (80% vs. 8%). The absolute value and the rate of Type 1 GC increased significantly from the first half to the second half of the study. CONCLUSIONS: Our findings showed that when Type 1 GC is discovered, physicians should investigate the mucosa around the main neoplasm carefully. The current series suggested that Type 1 GC are associated frequently with superficial lesions, making local resections more difficult, and that Type 1 GC was similar clinicopathologically to carcinoma of the gastric cardia and had different etiologies contributed to its tumorgenesis, compared with non-Type 1 GC, and Type 1 GC may become the key which solves the problem of carcinoma at the gastric cardia.


Assuntos
Carcinoma/patologia , Neoplasias Gástricas/patologia , Adulto , Idoso , Idoso de 80 Anos ou mais , Carcinoma/cirurgia , Feminino , Gastrectomia , Humanos , Masculino , Pessoa de Meia-Idade , Invasividade Neoplásica , Estadiamento de Neoplasias , Neoplasia Residual , Estudos Retrospectivos , Neoplasias Gástricas/cirurgia
19.
World J Gastroenterol ; 12(5): 703-8, 2006 Feb 07.
Artigo em Inglês | MEDLINE | ID: mdl-16521182

RESUMO

AIM: To estimate whether STI571 inhibits the expression of vascular endothelial growth factor (VEGF) in the gastrointestinal stromal tumor (GIST) cells. METHODS: We used GIST cell line, GIST-T1. It has a heterogenic 57-bp deletion in exon 11 to produce a mutated c-KIT, which results in constitutive activation of c-KIT. Cells were treated with/without STI571 or stem cell factor (SCF). Transcription and expression of VEGF were determined by RT-PCR and flow cytometry or Western blotting, respectively. Activated c-KIT was estimated by immunoprecipitation analysis. Cell viability was determined by MTT assay. RESULTS: Activation of c-KIT was inhibited by STI571 treatment. VEGF was suppressed at both the transcriptional and translational levels in a temporal and dose-dependent manner by STI571. SCF upregulated the expression of VEGF and it was inhibited by STI571. STI571 also reduced the cell viability of the GIST-T1 cells, as determined by MTT assay. CONCLUSION: Activation of c-KIT in the GIST-T1 regulated the expression of VEGF and it was inhibited by STI571. STI571 has antitumor effects on the GIST cells with respect to not only the inhibition of cell growth, but also the suppression of VEGF expression.


Assuntos
Antineoplásicos/uso terapêutico , Neoplasias Gastrointestinais/tratamento farmacológico , Neoplasias Gastrointestinais/genética , Piperazinas/uso terapêutico , Pirimidinas/uso terapêutico , Fator A de Crescimento do Endotélio Vascular/genética , Sequência de Bases , Benzamidas , Linhagem Celular Tumoral , Sobrevivência Celular/efeitos dos fármacos , DNA/genética , Neoplasias Gastrointestinais/metabolismo , Neoplasias Gastrointestinais/patologia , Expressão Gênica/efeitos dos fármacos , Humanos , Subunidade alfa do Fator 1 Induzível por Hipóxia/genética , Mesilato de Imatinib , Mutação , Proteínas Proto-Oncogênicas c-kit/genética , Proteínas Proto-Oncogênicas c-kit/metabolismo
20.
World J Gastroenterol ; 12(9): 1412-5, 2006 Mar 07.
Artigo em Inglês | MEDLINE | ID: mdl-16552811

RESUMO

AIM: To examine the paclitaxel concentrations in plasma and ascites after its intravenous administration in patients with ascites due to peritonitis carcinomatosa resulting from advanced gastric cancer. METHODS: Two patients with ascites due to peritonitis carcinomatosa resulting from gastric cancer were included in this study. The paclitaxel concentrations in plasma and ascites were investigated for 72 h in case 1 and 168 h in case 2 after intravenous administration. RESULTS: The paclitaxel concentration in plasma peaked immediately after administration, followed by rapid decrease below the threshold value of 0.1 micromol (85 ng/mL) within 24 h. In contrast,the paclitaxel concentration in ascites increased gradually for 24 h after administration to a level consistent with the level found in plasma. After 24 h the level of paclitaxel in ascites and plasma became similar, with the optimal level being maintained up to 72 h following administration. CONCLUSION: The concentration of paclitaxel in ascites is maintained within the optimal level for the treatment of cancer cells for up to 72 h after intravenous administration. Paclitaxel is a promising drug for the treatment of malignant ascites of gastric cancer.


Assuntos
Antineoplásicos Fitogênicos/farmacocinética , Ascite/metabolismo , Paclitaxel/farmacocinética , Neoplasias Gástricas/tratamento farmacológico , Antineoplásicos Fitogênicos/sangue , Antineoplásicos Fitogênicos/uso terapêutico , Ascite/tratamento farmacológico , Ascite/etiologia , Ascite/patologia , Líquido Ascítico/química , Líquido Ascítico/patologia , Humanos , Paclitaxel/sangue , Paclitaxel/uso terapêutico , Peritonite/patologia , Neoplasias Gástricas/metabolismo , Neoplasias Gástricas/patologia , Fatores de Tempo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA